Inflammation & Wound Healing Pathology

Acute Inflammation

Inflammation's five cardinal signs, rubor (redness), calor (heat), tumor (swelling), dolor (pain), and functio laesa (loss of function), describe the same underlying vascular and cellular response regardless of tissue. The first four are classically attributed to Celsus; the fifth, functio laesa, is most often credited to Galen, though the attribution is genuinely disputed and has also been credited to Virchow and Sydenham.

The earliest vascular response, arteriolar dilation with increased postcapillary venule permeability, is driven by histamine (released from mast cells), serotonin (from platelets), and bradykinin (generated by activation of the kinin system). This vascular phase produces the redness, heat, and swelling directly.

On the cellular side, neutrophils are the first cells recruited to acute infection or injury, arriving within hours. They phagocytose bacteria, release antimicrobial enzymes, and generate reactive oxygen species. This is the first line of cellular innate defense, distinct from the mononuclear cell response of chronic inflammation described below.

The Complement System

Different complement fragments serve distinct roles in ocular inflammation. C5a is the most potent complement-derived chemotactic factor: it recruits neutrophils and monocytes to sites of complement activation and activates mast cells, increasing vascular permeability. C3b instead acts as an opsonin, enhancing phagocytosis rather than recruiting cells.

The cascade's terminal step assembles the membrane attack complex (MAC) from complement components C5b through C9. MAC causes direct cell lysis by inserting into the target cell's lipid bilayer, forming a transmembrane pore that allows uncontrolled ion flux and water entry, producing osmotic lysis. This mechanism is directly relevant to complement-mediated retinal and corneal disease.

Complement genetics matter clinically well beyond acute inflammation. Chronic, low-grade activation of the alternative complement pathway is strongly implicated in dry age-related macular degeneration. The CFH Y402H polymorphism (a variant of complement factor H) confers the highest population-attributable genetic risk for AMD identified in genome-wide association studies. CFH normally inhibits the alternative pathway by competing with factor B for C3b binding. The Y402H substitution reduces CFH's ability to restrain complement activation on RPE and Bruch's membrane surfaces, leading to chronic alternative-pathway activation, progressive drusen formation, and AMD progression.

Chronic and Granulomatous Inflammation

Where acute inflammation is dominated by neutrophils, chronic inflammation is characterized histologically by mononuclear cells: lymphocytes (mediating the adaptive immune response), plasma cells (producing antibodies), and macrophages (phagocytosis and cytokine secretion). Tissue destruction and attempted repair often occur simultaneously rather than sequentially.

Granulomatous inflammation is a specific, distinctive pattern within the chronic inflammation spectrum: aggregates of epithelioid macrophages (activated macrophages with abundant pink cytoplasm resembling epithelial cells), often accompanied by Langhans or foreign-body-type giant cells. It occurs classically in tuberculosis, sarcoidosis, fungal infection, and foreign body reactions. IFN-γ, produced by CD4+ Th1 lymphocytes, drives this transformation: it activates macrophages to differentiate into epithelioid cells and promotes their fusion into multinucleate giant cells. Epithelioid macrophage aggregates, usually with giant cells, are the histologic hallmark that distinguishes granulomatous inflammation from ordinary chronic inflammation.

Apoptosis versus Necrosis

Apoptosis is regulated, programmed cell death, characterized by cell shrinkage, chromatin condensation, membrane blebbing, and orderly phagocytosis of the resulting apoptotic bodies. Critically, it occurs without triggering inflammation. Necrosis, by contrast, is uncontrolled cell death that ruptures the cell membrane and releases intracellular contents into the surrounding tissue, which is exactly what triggers an inflammatory response. The distinction matters throughout ocular pathology: a disease process driven by necrosis, such as acute retinal necrosis, inherently carries an inflammatory component that a purely apoptotic process would not.

Necrosis itself is not one pattern. The default response to ischemia in most tissues is coagulative necrosis, which leaves cell outlines recognizable for days even as nuclear detail is lost, the pattern produced by angioinvasive rhino-orbital mucormycosis thrombosing the vessels it invades. Bacterial infection instead tends toward liquefactive necrosis: enzymes digest dying tissue into a viscous mass, the same process behind pus formation and the rapid stromal melt of severe Pseudomonas keratitis. Tuberculous granulomas, including the choroidal tubercles of ocular tuberculosis, undergo caseous necrosis instead, obliterating tissue architecture rather than preserving it. A fourth pattern, fibrinoid necrosis, targets vessel walls directly, driven by immune-complex deposition, and underlies the vasculitis of necrotizing scleritis in rheumatoid arthritis.

Wound Healing and Granulation Tissue

The proliferative phase of wound healing is marked by ingrowth of new capillaries, angiogenesis driven by VEGF, alongside fibroblast proliferation, with those fibroblasts producing collagen. Together these form granulation tissue: new capillary loops, fibroblasts, and loose connective tissue that replaces the provisional fibrin matrix before it remodels into mature scar tissue.

Corneal Wound Healing, Scarring, and Transparency

Corneal epithelial healing follows a defined sequence: remaining epithelial cells first migrate to cover the defect within hours, then proliferate to restore normal cell numbers, then re-establish the basement membrane over days to weeks. In parallel, the underlying stromal keratocytes activate and begin remodeling the stroma itself.

Corneal neovascularization after injury is driven primarily by VEGF-A, released by hypoxic or inflamed corneal epithelium and by infiltrating stromal macrophages. VEGF-A binds VEGFR-2 on limbal vascular endothelial cells, stimulating their proliferation and migration into the normally avascular corneal stroma.

Beyond neovascularization, injury can also produce lasting corneal scarring (haze). TGF-β1, released from the tear film, the epithelium, and infiltrating inflammatory cells, converts quiescent keratocytes into myofibroblasts. These are the cells responsible for producing the opaque, disorganized collagen fibrils that make up a corneal scar, and for the contractile forces relevant to haze after refractive surgery and to keratoconus progression.

The optical basis of that opacity comes down to collagen ultrastructure. Normal corneal transparency depends on collagen fibrils of highly uniform diameter (roughly 25-30 nm) arranged with precise, regular spacing: a lattice that transmits light with minimal scatter. Scar tissue instead contains collagen fibrils of irregular diameter and disorganized spacing throughout the stroma. That disrupted lattice scatters rather than transmits light, the direct structural reason a scarred cornea is opaque while a healthy one is clear. The same principle explains the opacification seen in keloid-like corneal scars, climatic droplet keratopathy, and band keratopathy.

Clinical Applications

This same wound-healing biology (fibroblast activation, collagen deposition, myofibroblast transdifferentiation) reappears as the central mechanism in several distinct clinical problems well outside the cornea.

Trabeculectomy Bleb Fibrosis

After trabeculectomy, subconjunctival and sub-Tenon's capsule fibrosis is the main cause of filtering bleb failure. Tenon's fibroblasts, activated by TGF-β (from the aqueous humor and the general wound-healing cascade) and PDGF, proliferate and deposit collagen, contracting and scarring the bleb closed. This is the direct pathologic rationale for using antifibrotic agents intraoperatively or postoperatively to inhibit that same fibroblast proliferation.

Mitomycin-C (MMC) and 5-fluorouracil (5-FU), the two antifibrotics used in glaucoma surgery, work through genuinely different mechanisms. MMC is an alkylating agent that cross-links DNA directly, blocking fibroblast replication, and is generally more potent than 5-FU. 5-FU instead is an antimetabolite that inhibits thymidylate synthase, halting pyrimidine (dTMP) synthesis and blocking fibroblast DNA replication that way. Both can be used intraoperatively or as postoperative subconjunctival injections.

Proliferative Vitreoretinopathy (PVR)

PVR is the retinal-surgery analogue of the same process. Retinal pigment epithelial cells (which reach the vitreous through a retinal break) and Müller glial cells (which grow out onto the retinal surface) undergo epithelial-to-mesenchymal transition (EMT), transdifferentiating into myofibroblast-like cells that proliferate and form contractile membranes on the retinal surface (epiretinal) and beneath the retina (subretinal). The resulting traction causes tractional retinal detachment, and PVR is the major cause of failed retinal detachment repair.

NF-κB Signaling

NF-κB is the central transcriptional regulator threading through nearly all of ocular inflammation, activated by diverse upstream stimuli: bacterial LPS via TLR4, TNF-α via TNFR1, IL-1β via IL-1R, and oxidative stress, among others. VEGF signaling via VEGFR-2 is a notable exception. It signals primarily through the PI3K/Akt and MAPK/ERK pathways for angiogenesis rather than through NF-κB, so despite some crosstalk between the pathways, NF-κB is not VEGF's primary downstream effector.

Related Topics

Continue exploring Basic Sciences: